These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6219633)

  • 1. Suppressor cell decrease in alopecia areata.
    Ledesma GN; York KK
    Arch Dermatol Res; 1982; 274(1-2):1-8. PubMed ID: 6219633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoimmunity in alopecia areata. An assessment in 100 patients].
    Lutz G; Bauer R
    Hautarzt; 1988 Jan; 39(1):5-11. PubMed ID: 2965691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased ratio of helper to suppressor T cells in alopecia areata.
    Majewski BB; Koh MS; Taylor DR; Watson B; Rhodes EL
    Br J Dermatol; 1984 Feb; 110(2):171-5. PubMed ID: 6230097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor cell number and function in alopecia areata.
    Hordinsky MK; Hallgren H; Nelson D; Filipovich AH
    Arch Dermatol; 1984 Feb; 120(2):188-94. PubMed ID: 6230058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proliferative activity and regulatory subpopulations of T lymphocytes in various forms of alopecia].
    Kulagin Vi; Cheredeev AN; Liakhov VF
    Vestn Dermatol Venerol; 1988; (1):10-4. PubMed ID: 2966508
    [No Abstract]   [Full Text] [Related]  

  • 6. The correlation between inducer/suppressor ratios, generation of concanavalin A-activated suppressor cells, and mitogen-stimulated proliferation of peripheral blood lymphocytes in patients with alopecia areata and normal controls.
    Filipovich AH; Hordinsky-Kramarczuk M; Nelson D; Hallgren H
    Clin Immunol Immunopathol; 1982 Oct; 25(1):21-31. PubMed ID: 6217938
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of peripheral T-cell subpopulations and lymphocyte proliferation in different phases of evolution of alopecia areata.
    Mak CP; Wu YC; Chang CH; Hsieh RP; Lü YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 May; 20(2):95-103. PubMed ID: 3498608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiological studies on the alopecic (DEBR) rat.
    Michie HJ; Jahoda CA; Oliver RF; Poulton TA
    Br J Dermatol; 1990 Nov; 123(5):557-67. PubMed ID: 2147388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial alopecia areata. HLA antigens and autoantibody formation in an American family.
    Hordinsky MK; Hallgren H; Nelson D; Filipovich AH
    Arch Dermatol; 1984 Apr; 120(4):464-8. PubMed ID: 6231002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata: autoimmunity--the evidence is compelling.
    Kalish RS; Gilhar A
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
    Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistologic and ultrastructural comparison of the dermal papilla and hair follicle bulb from "active" and "normal" areas of alopecia areata.
    Hull SM; Nutbrown M; Pepall L; Thornton MJ; Randall VA; Cunliffe WJ
    J Invest Dermatol; 1991 May; 96(5):673-81. PubMed ID: 1827135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata.
    Tembhre MK; Sharma VK
    Br J Dermatol; 2013 Sep; 169(3):543-8. PubMed ID: 23607748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic competition as a therapeutic concept for alopecia areata.
    Happle R
    Arch Dermatol Res; 1980; 267(1):109-14. PubMed ID: 6446265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased lymphocyte reactivity and auto-immunity in alopecia areata.
    Friedmann PS
    Br J Dermatol; 1981 Aug; 105(2):145-51. PubMed ID: 6974565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral T-cell subsets in patients with alopecia areata in different clinical phases.
    Valsecchi R; Bontempelli M; Vicari O; Frigeni A; Foiadelli L; Cainelli T
    Dermatologica; 1985; 171(3):170-4. PubMed ID: 3908169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata, autoimmunity, and Down's syndrome.
    Du Vivier A; Munro DD
    Br Med J; 1975 Jan; 1(5951):191-2. PubMed ID: 122906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating lymphocyte subsets in patients with alopecia areata.
    Baadsgaard O; Lindskov R
    Acta Derm Venereol; 1986; 66(3):266-8. PubMed ID: 2426908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata.
    Elela MA; Gawdat HI; Hegazy RA; Fawzy MM; Abdel Hay RM; Saadi D; Shaker O
    Arch Dermatol Res; 2016 Mar; 308(2):115-21. PubMed ID: 26796544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.